Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml
Pharmacopsychiatry 2006; 39(3): 117-118
DOI: 10.1055/s-2006-941489
DOI: 10.1055/s-2006-941489
Letter
© Georg Thieme Verlag KG Stuttgart · New York
Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder
A Case ReportFurther Information
Publication History
Received: 19.9.2005
Revised: 18.1.2006
Accepted: 13.2.2006
Publication Date:
23 May 2006 (online)


Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES).New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients.